Lysis of Epidural Lesions (Epidural Adhesiolysis)
Customize your policy alerts
Sign up for Ambetter Georgia Policy CP.MP.116 alerts
Get alerted when Policy CP.MP.116 changes without checking for updates manually.
Monitor payer policy activity
Defines the payer's coverage stance and clinical rationale for percutaneous and endoscopic lysis of epidural adhesions (epidural adhesiolysis) for adults with chronic low back and/or lower extremity pain, and describes related coding guidance. Affects providers submitting claims to Ambetter Georgia.
No material clinical or coverage changes in this revision.
Coverage Determination
Overall coverage stance
Policy-level stance indicating lack of support for efficacy.
The policy concludes that current medical literature does not support the efficacy of lysis of epidural lesions, including both percutaneous epidural adhesiolysis and endoscopic epidural adhesiolysis. This statement reflects the plan's evidence-based review and is the basis for coverage determinations described in this policy.
Specifically, lysis of epidural lesions (percutaneous and endoscopic adhesiolysis), with or without an indwelling Racz catheter, is not supported
When state Medicaid coverage provisions conflict with this clinical policy, state Medicaid coverage provisions take precedence. Providers should consult the applicable state Medicaid manual for any differing coverage rules prior to applying this policy to Medicaid members.
Procedure Coding
| 62263 | Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 2 or more days. |
| 62264 | Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 1 day. |
Provider Responsibilities & Billing Guidance
Prior authorization / coding note — CPT 62263, 62264
CPT codes 62263 and 62264 are referenced in this policy for informational purposes; inclusion or exclusion of codes in the policy does not guarantee coverage. Confirm whether prior authorization is required and verify appropriate coding before claim submission.
Verify coverage and prior authorization per member EOC/contract
Verify member coverage, benefit limitations, and any prior authorization requirements before scheduling procedures; this policy is a guide to medical necessity and does not guarantee payment.
- Check the member's evidence of coverage/certificate of coverage/contract for benefit-specific terms.
- Confirm prior authorization requirements with the Health Plan before providing services.
Document failure of conservative therapy before considering adhesiolysis
Clinical guidelines and systematic reviews cited in the policy emphasize that patients considered for adhesiolysis typically have failed conservative therapies; document prior conservative management attempts.
- Hayes review (2018) found potential short- and intermediate-term benefit in patients who failed conservative treatment but noted low-quality evidence.
- ASIPP (2021) recommends prior failure of conservative treatment and fluoroscopically guided epidural injections before considering adhesiolysis.
Reference up-to-date coding guidance (CPT 62263, 62264)
Reference current professional coding guidance prior to claim submission and use the CPT descriptions shown in the policy as informational references only.
- Providers should reference the most up-to-date sources of professional coding guidance prior to submitting claims for reimbursement.
- Codes included in the policy are informational; inclusion or exclusion does not guarantee coverage.
Providers and members are bound by coverage contract terms
Providers, members/enrollees and their representatives are contractually bound by the terms and conditions of the member's coverage documents; providers should follow those contract terms when delivering services or submitting claims.
- Where no contract exists, providing services or submitting claims constitutes agreement to the policy terms.
- State Medicaid provisions take precedence if they conflict with this clinical policy.
Efficacy not supported by current medical literature — denial risk
The policy states that current medical literature does not support the efficacy of lysis of epidural lesions (percutaneous and endoscopic), which may result in denial of coverage or claims being considered not medically necessary.
- Percutaneous and endoscopic epidural adhesiolysis, with or without an indwelling Racz catheter, are noted as not supported by current medical literature per the policy statement.
Coverage decisions subject to all plan terms, exclusions and limitations
Coverage and benefit administration are subject to all terms, conditions, exclusions and limitations of the coverage documents; claims inconsistent with those documents may be denied.
- This clinical policy is a guide to medical necessity and does not constitute a contract or guarantee of payment.
- Review applicable Health Plan-level administrative policies and state/federal requirements.
Provider action checklist (document, verify, confirm implications of policy)
Providers should follow the policy's provider-impact statements: reference evidence and coding guidance, document conservative-treatment failures, confirm benefits and authorization requirements, and recognize the policy does not guarantee payment.
Conservative Care Context
Conservative treatment requirements (clinical context)
Clinical literature and professional guidelines evaluating epidural adhesiolysis typically describe these procedures in patients who have failed conservative treatment; include the following contextual statements from cited sources.
Summarizes Hayes review findings as context; does not alter policy coverage stance.
Guideline-level recommendation references prior failure of conservative therapy as part of patient selection in cited guidance; policy coverage conclusion remains based on overall literature assessment.
Imaging and Procedural Guidance
Imaging requirement — fluoroscopic localization and endoscopic guidance
Fluoroscopic localization is referenced in CPT descriptions for percutaneous adhesiolysis and endoscopic guidance (providing 3-D visualization) is described in the background; use of imaging guidance is part of the procedural description.
- CPT descriptors include radiologic localization as part of the procedure
- Endoscopic procedures use a flexible fiberoptic catheter to provide 3‑D visualization of adhesions
Definitions
Background
Epidural adhesiolysis (also described as lysis of epidural lesions or epidural neuroplasty) is a minimally invasive interventional procedure intended to treat chronic low back and/or lower extremity pain thought to be related to epidural fibrosis or adhesions. Techniques include injection of solutions (for example, hypertonic saline, enzymes, or steroids) and/or mechanical disruption using specialized catheters; some approaches use endoscopic visualization to target and directly lyse scar tissue. Although these procedural descriptions are recognized in the literature, this policy determines that available evidence does not support their efficacy for coverage purposes.
Not Covered Items
Not covered: Lysis of epidural lesions, including percutaneous epidural adhesiolysis and endoscopic epidural adhesiolysis, with or without an indwelling epidural Racz catheter, is not supported by the current medical literature and is therefore not covered under this policy.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.